CASE REPORTS
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Successful plasmapheresis in Bickerstaff's brain stem encephalitis associated with anti-GQ1b antibody.

Patients with Guillain-Barré syndrome (GBS) and Fisher's syndrome (FS) benefit from plasmapheresis. Specific treatments, however, have yet to be established for Bickerstaff's brain stem encephalitis (BBE). We showed earlier that sera from BBE patients, as well as from patients with FS and GBS with ophthalmoplegia, have autoantibody to GQ1b ganglioside in the acute phase of the disease. We report 2 BBE patients who had high IgG anti-GQ1b antibody titers and were treated successfully with plasmapheresis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app